---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-018333"
form_type: "8-K"
ticker: "PRPH"
cik: "0000868278"
company_name: "ProPhase Labs, Inc."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T07:56:16.197264+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ProPhase Labs Q1 net loss $6.3M; revenue drops to $3.6M; explores sale of Pharmaloz

## Summary
- Net loss of $6.3M ($0.07 loss per share) vs net income of $0.6M ($0.03 EPS) in Q1 2023.
- Revenue declined 81% to $3.6M from $19.3M, driven by zero COVID-19 testing vs 120K tests year ago.
- Pharmaloz Manufacturing exploring strategic alternatives including potential sale; signed two deals worth >$5M annual additional revenue.
- BE-Smart esophageal cancer test on track for H2 2024 commercialization; Project ZenQ-AI launched using AI for cancer therapy.
- Cash at April 30: $4.6M; raised $2.5M via receivables securitization and $3.6M from partial investment sale.

## SEC filing metadata
- accession: 0001493152-24-018333
- form_type: 8-K
- ticker: PRPH
- cik: 0000868278
- company_name: ProPhase Labs, Inc.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/868278/000149315224018333/0001493152-24-018333-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/868278/000149315224018333/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-018333
- JSON: https://secwatch.observer/filing/0001493152-24-018333.json
- Plain text: https://secwatch.observer/filing/0001493152-24-018333.txt

## Key facts
- Earnings Releases
  ProPhase Labs, Inc. reported financial results for first quarter ended March 31, 2024.
  - Period: first quarter ended March 31, 2024
  - Result: reported results
  source text: On May 9, 2024, ProPhase Labs, Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/868278/000149315224018333/0001493152-24-018333-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.